Leiomyosarcoma News and Research

RSS
Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Study suggests how existing and emerging immunotherapy treatments could be successful for sarcomas

Implementation of large-scale genomic tumor profiling viable but faces several challenges

Implementation of large-scale genomic tumor profiling viable but faces several challenges

Experts to analyse latest advances in diagnosis, treatment of soft tissue sarcoma at PharmaMar seminar

Experts to analyse latest advances in diagnosis, treatment of soft tissue sarcoma at PharmaMar seminar

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

Eisai's Halaven receives FDA approval for treatment of patients with metastatic liposarcoma

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

FDA approves Yondelis (trabectedin) for treatment of specific soft tissue sarcomas

Houston Methodist Hospital and MD Anderson Cancer Center surgeons successfully perform multi-organ transplant

Houston Methodist Hospital and MD Anderson Cancer Center surgeons successfully perform multi-organ transplant

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Laparoscopic hysterectomy with morcellation safer than abdominal procedure for treating presumed fibroid uterus

Laparoscopic hysterectomy with morcellation safer than abdominal procedure for treating presumed fibroid uterus

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Janssen granted Priority Review from FDA for YONDELIS (trabectedin) NDA to treat STS patients

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

UCSD researchers define epidemiology of gastrointestinal stromal tumors

UCSD researchers define epidemiology of gastrointestinal stromal tumors

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Injections of anaerobic bacteria can shrink tumors in rats, dogs and human

Glimmer of hope for imatinib-resistant GIST

Glimmer of hope for imatinib-resistant GIST

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

Exelix reports preliminary data from cabozantinib phase 1 study on solid tumors

Orthopaedic research studies in the Journal of Bone and Joint Surgery

Orthopaedic research studies in the Journal of Bone and Joint Surgery

IRCI to design and fund clinical trials for rare cancers

IRCI to design and fund clinical trials for rare cancers

Mount Sinai researchers identify protein signaling hyperactivity in human sarcoma cells

Mount Sinai researchers identify protein signaling hyperactivity in human sarcoma cells

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO

Lilly's cixutumumab Phase II study results in five subtypes of sarcoma to be presented at 47th ASCO